AnySelected

Alphabet's AI-Powered Drug Development: A Game-Changer Ahead of Earnings?

MSN

CNBC's Deirdre Bosa and Big Technology's Alex Kantrowitz join forces to discuss the potential impact of Alphabet's AI-driven drug development on the company's upcoming earnings. With experts weighing in, this innovative approach could be a significant tailwind for the tech giant. As the intersection of technology and healthcare continues to grow, Alphabet's foray into AI-powered drug development is an exciting space to watch, particularly with the rise of artificial intelligence and machine learning. Get the latest insights ahead of the earnings report.